Sponsor Pipeline

Seaport Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07065240 A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With… Major Depressive Disorder (MDD) Recruiting
NCT07161700 An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300… Major Depressive Disorder (MDD) Enrolling by Invitation
Disease Areas
Depression (2)
Get alerts when Seaport Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free